The January/February 2008 issue of Harvard Medical International profiles Clayton Christensen and his thoughts on disruptive innovation in healthcare. Read about it on the Web at: http://www.hmiworld.org/hmi/issues/jan-feb08/briefcase.php.
With Massachusetts agreeing to allow the operation of retail health clinics, Christensen talks about the potential this business model innovation has to revolutionize the healthcare industry — and make it far simpler and affordable for all. He also talks about how molecular diagnostics — a technological enabler, which is key to disruption — over time can transform the diagnosis of disease and ultimately improve treatment.
